Postoperative 20% Albumin Infusion and Acute Kidney Injury in High-Risk Cardiac Surgery Patients: The ALBICS AKI Randomized Clinical Trial

A trial testing concentrated 20% albumin after high-risk cardiac surgery found it did not protect the kidneys and instead increased acute kidney injury, particularly in patients with reduced baseline kidney function.